Risk and Outcomes of Reintervention After Transcatheter Aortic Valve Implantation
Listen to this summary
This study investigates the time-varying risk and outcomes of reintervention after transcatheter aortic valve implantation (TAVI) in Medicare patients. The authors found that the hazard of reintervention increased significantly over time, particularly after 7 years, with valve stenosis being the most common reason for reintervention. While mortality rates remained consistent across different time intervals, the risk of heart failure hospitalizations was notably higher following early reinterventions, suggesting a need for tailored post-TAVI care.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from The Annals of thoracic surgery
View all →Jun 9, 2026 · The Annals of thoracic surgery
Graft-Assisted Transapical Transcatheter Aortic Valve Replacement with Concomitant Robotic Minimally Invasive Direct Coronary Artery Bypass
Jun 9, 2026 · The Annals of thoracic surgery
Preoperative Resting Heart Rate and 30-Day Heart Failure After Off-Pump Coronary Artery Bypass Grafting
Jun 9, 2026 · The Annals of thoracic surgery
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Jun 24, 2026 · The New England journal of medicine
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
Jun 24, 2026 · The New England journal of medicine
Prevention and Treatment of Peanut Allergy
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
Jun 24, 2026 · JAMA
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial
Jun 24, 2026 · Lancet (London, England)
Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
